BOSTON SCIENTIFIC CORPORATION Increase (Decrease) in Inventories
BOSTON SCIENTIFIC CORPORATION (BSX) reported Increase (Decrease) in Inventories of $310.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-03
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in inventories for the quarter ending 2026-06-30 was $133.00M.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in inventories for the quarter ending 2026-03-31 was $177.00M, a 62.39% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in inventories for the quarter ending 2025-12-31 was $50.00M.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in inventories for the quarter ending 2025-09-30 was $94.00M, a 70.91% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in inventories for fiscal 2025 was $188.00M, a 17.54% decline from fiscal 2024.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in inventories for fiscal 2024 was $228.00M, a 65.45% decline from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in inventories for fiscal 2023 was $660.00M, a 105.61% increase from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION increase (decrease) in inventories for fiscal 2022 was $321.00M, a 7.23% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $133.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $310.00M 10-Q · filed 2026-08-03 | $360.00M derived: sum of 3 quarters · filed 2026-08-03 | $454.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2026-03-31 | $177.00M 10-Q · filed 2026-05-01 | $227.00M derived: sum of 2 quarters · filed 2026-05-01 | $321.00M derived: sum of 3 quarters · filed 2026-05-01 | $256.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $144.00M derived: sum of 2 quarters · filed 2026-02-17 | $79.00M derived: sum of 3 quarters · filed 2026-08-03 | $188.00M 10-K · filed 2026-02-17 | |
| 2025-09-30 | $94.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $29.00M derived: sum of 2 quarters · filed 2026-08-03 | $138.00M 10-Q · filed 2025-11-03 | $92.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-06-30 | -$65.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $44.00M 10-Q · filed 2026-08-03 | -$2.00M derived: sum of 3 quarters · filed 2026-08-03 | $53.00M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | $109.00M 10-Q · filed 2026-05-01 | $63.00M derived: sum of 2 quarters · filed 2026-05-01 | $118.00M derived: sum of 3 quarters · filed 2026-05-01 | $213.00M derived: sum of 4 quarters · filed 2026-05-01 | |
| 2024-12-31 | -$46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $9.00M derived: sum of 2 quarters · filed 2026-02-17 | $104.00M derived: sum of 3 quarters · filed 2026-02-17 | $228.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $55.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $150.00M derived: sum of 2 quarters · filed 2025-11-03 | $274.00M 10-Q · filed 2025-11-03 | $333.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-06-30 | $95.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $219.00M 10-Q · filed 2025-08-01 | $278.00M derived: sum of 3 quarters · filed 2026-02-17 | $480.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-03-31 | $124.00M 10-Q · filed 2025-05-01 | $183.00M derived: sum of 2 quarters · filed 2026-02-17 | $385.00M derived: sum of 3 quarters · filed 2026-02-17 | $599.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2023-12-31 | $59.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $261.00M derived: sum of 2 quarters · filed 2026-02-17 | $475.00M derived: sum of 3 quarters · filed 2026-02-17 | $660.00M 10-K · filed 2026-02-17 | |
| 2023-09-30 | $202.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $416.00M derived: sum of 2 quarters · filed 2024-11-01 | $601.00M 10-Q · filed 2024-11-01 | $647.00M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-06-30 | $214.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $399.00M 10-Q · filed 2024-08-01 | $445.00M derived: sum of 3 quarters · filed 2025-02-18 | $540.00M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-03-31 | $185.00M 10-Q · filed 2024-05-01 | $231.00M derived: sum of 2 quarters · filed 2025-02-18 | $326.00M derived: sum of 3 quarters · filed 2025-02-18 | $398.00M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2022-12-31 | $46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $141.00M derived: sum of 2 quarters · filed 2025-02-18 | $213.00M derived: sum of 3 quarters · filed 2025-02-18 | $321.00M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $95.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $167.00M derived: sum of 2 quarters · filed 2023-11-01 | $275.00M 10-Q · filed 2023-11-01 | $306.00M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-06-30 | $72.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $180.00M 10-Q · filed 2023-08-03 | $211.00M derived: sum of 3 quarters · filed 2024-02-20 | $426.00M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2022-03-31 | $108.00M 10-Q · filed 2023-05-04 | $139.00M derived: sum of 2 quarters · filed 2024-02-20 | $354.00M derived: sum of 3 quarters · filed 2024-02-20 | $339.00M derived: sum of 4 quarters · filed 2024-02-20 | |
| 2021-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $246.00M derived: sum of 2 quarters · filed 2024-02-20 | $231.00M derived: sum of 3 quarters · filed 2024-02-20 | $346.00M 10-K · filed 2024-02-20 | |
| 2021-09-30 | $215.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $200.00M derived: sum of 2 quarters · filed 2022-11-03 | $315.00M 10-Q · filed 2022-11-03 | $379.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | -$15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $100.00M 10-Q · filed 2022-08-04 | $164.00M derived: sum of 3 quarters · filed 2023-02-23 | $129.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $115.00M 10-Q · filed 2022-05-05 | $179.00M derived: sum of 2 quarters · filed 2023-02-23 | $144.00M derived: sum of 3 quarters · filed 2023-02-23 | -$19.00M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $64.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $29.00M derived: sum of 2 quarters · filed 2023-02-23 | -$134.00M derived: sum of 3 quarters · filed 2023-02-23 | $65.00M 10-K · filed 2023-02-23 | |
| 2020-09-30 | -$35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$198.00M derived: sum of 2 quarters · filed 2021-11-04 | $1.00M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | -$163.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $36.00M 10-Q · filed 2021-08-06 | |||
| 2020-03-31 | $199.00M 10-Q · filed 2021-05-06 | ||||
| 2019-12-31 | $290.00M 10-K · filed 2022-02-23 | ||||
| 2018-12-31 | $83.00M 10-K · filed 2021-02-23 | ||||
| 2017-12-31 | $107.00M 10-K · filed 2020-02-25 | ||||
| 2016-12-31 | -$40.00M 10-K · filed 2019-02-19 | ||||
| 2015-12-31 | -$3.00M 10-K · filed 2018-02-20 | ||||
| 2014-12-31 | $81.00M 10-K · filed 2017-02-23 | ||||
| 2013-12-31 | $7.00M 10-K · filed 2016-02-24 | ||||
| 2012-12-31 | -$66.00M 10-K · filed 2015-02-25 | ||||
| 2011-12-31 | $54.00M 10-K · filed 2014-02-26 | ||||
| 2010-12-31 | $5.00M 8-K · filed 2013-05-29 | ||||
| 2009-12-31 | $92.00M 10-K · filed 2012-02-17 | -$92.00M 10-K · filed 2010-02-26 | |||
| 2008-12-31 | $120.00M 10-K · filed 2011-02-17 | -$120.00M 10-K · filed 2010-02-26 | |||
| 2007-12-31 | -$30.00M 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |